AR223487A1 - Procedimientos para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina - Google Patents

Procedimientos para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina

Info

Publication number
AR223487A1
AR223487A1 AR276536A AR27653679A AR223487A1 AR 223487 A1 AR223487 A1 AR 223487A1 AR 276536 A AR276536 A AR 276536A AR 27653679 A AR27653679 A AR 27653679A AR 223487 A1 AR223487 A1 AR 223487A1
Authority
AR
Argentina
Prior art keywords
piperidinoquinazoline
procedures
amino
preparation
new derivatives
Prior art date
Application number
AR276536A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR223487A1 publication Critical patent/AR223487A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AR276536A 1978-05-18 1979-05-16 Procedimientos para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina AR223487A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2035178 1978-05-18

Publications (1)

Publication Number Publication Date
AR223487A1 true AR223487A1 (es) 1981-08-31

Family

ID=10144517

Family Applications (2)

Application Number Title Priority Date Filing Date
AR276536A AR223487A1 (es) 1978-05-18 1979-05-16 Procedimientos para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
AR283021A AR224784A1 (es) 1978-05-18 1980-10-28 Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR283021A AR224784A1 (es) 1978-05-18 1980-10-28 Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina

Country Status (30)

Country Link
US (1) US4243666A (fr)
JP (1) JPS554370A (fr)
AR (2) AR223487A1 (fr)
AT (1) ATA363379A (fr)
AU (1) AU512947B2 (fr)
BE (1) BE876297A (fr)
CA (1) CA1240325A (fr)
CH (1) CH643553A5 (fr)
CS (1) CS214796B2 (fr)
DD (1) DD143613A5 (fr)
DE (1) DE2919800A1 (fr)
DK (1) DK159079A (fr)
ES (2) ES480671A1 (fr)
FI (1) FI64589C (fr)
FR (1) FR2434162A1 (fr)
GR (1) GR72824B (fr)
HU (1) HU182562B (fr)
IL (1) IL57297A (fr)
IN (1) IN153045B (fr)
IT (1) IT1114222B (fr)
LU (1) LU81284A1 (fr)
NL (1) NL172157C (fr)
NO (1) NO791648L (fr)
NZ (1) NZ190465A (fr)
PH (1) PH14802A (fr)
PL (2) PL121158B1 (fr)
PT (1) PT69622A (fr)
SE (1) SE439306B (fr)
YU (2) YU115279A (fr)
ZA (1) ZA792390B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
JPS5962766U (ja) * 1982-06-30 1984-04-25 守田 智 小動物用給水器
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
KR20030069218A (ko) * 2001-01-18 2003-08-25 다케다 야쿠힌 고교 가부시키가이샤 벤질피페리딘 화합물의 제조 방법
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
MXPA06005019A (es) * 2003-11-03 2006-07-06 Warner Lambert Co Nuevos inhibidores de la recaptacion de norpinefrina para el tratamiento de transtornos del sistema nervioso central.
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
WO2008122776A2 (fr) * 2007-04-04 2008-10-16 Cipla Limited Procédé de préparation de l'erlotinib et de ses sels pharmaceutiquement acceptables
KR20100102646A (ko) * 2007-12-11 2010-09-24 가부시키가이샤 사이토파스파인더 카르복스아미드 화합물 및 케모카인 수용체 길항제로서의 이의 용도
BRPI0922010A2 (pt) * 2008-11-14 2015-12-15 Hoffmann La Roche dervivados de quinazolina como antagonistas receptores de nk3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
FR2321890A1 (fr) * 1975-08-26 1977-03-25 Synthelabo Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf

Also Published As

Publication number Publication date
IT1114222B (it) 1986-01-27
GR72824B (fr) 1983-12-06
CS214796B2 (en) 1982-05-28
IT7922720A0 (it) 1979-05-16
HU182562B (en) 1984-02-28
PL120651B1 (en) 1982-03-31
AU4710179A (en) 1979-11-22
SE439306B (sv) 1985-06-10
DE2919800A1 (de) 1979-11-22
AU512947B2 (en) 1980-11-06
PL215626A1 (fr) 1980-08-25
NL172157B (nl) 1983-02-16
ZA792390B (en) 1980-07-30
PL223844A1 (fr) 1981-01-02
JPS5623992B2 (fr) 1981-06-03
YU256382A (en) 1983-04-30
ES480671A1 (es) 1980-08-16
YU115279A (en) 1983-04-30
ES488210A0 (es) 1980-12-16
NO791648L (no) 1979-11-20
DK159079A (da) 1979-11-19
CH643553A5 (de) 1984-06-15
PL121158B1 (en) 1982-04-30
IL57297A (en) 1983-02-23
US4243666A (en) 1981-01-06
AR224784A1 (es) 1982-01-15
NZ190465A (en) 1981-05-01
LU81284A1 (fr) 1980-12-16
NL7903853A (nl) 1979-11-20
FR2434162A1 (fr) 1980-03-21
BE876297A (fr) 1979-11-16
JPS554370A (en) 1980-01-12
ATA363379A (de) 1983-05-15
DD143613A5 (de) 1980-09-03
FI64589C (fi) 1983-12-12
PT69622A (en) 1979-06-01
CA1240325A (fr) 1988-08-09
NL172157C (nl) 1983-07-18
ES8101584A1 (es) 1980-12-16
IN153045B (fr) 1984-05-26
FI64589B (fi) 1983-08-31
PH14802A (en) 1981-12-14
FI791562A7 (fi) 1979-11-19
IL57297A0 (en) 1979-09-30
FR2434162B1 (fr) 1983-04-22
SE7904358L (sv) 1979-11-19

Similar Documents

Publication Publication Date Title
MX6749E (es) Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
ES481909A0 (es) Procedimiento para la preparacion de nuevas aril-3 eter-5 o-xazolidinonas-2
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
MX7623E (es) Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas
MX5578E (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
ES492566A0 (es) Procedimiento para la preparacion de nuevos derivados de en-cafalina
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
MX5509E (es) Procedimiento para la preparacion de n-halogenoacetil-fenilaminocarboniloximas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
ES500384A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
MX6232E (es) Procedimiento para la preparacion de auronas substituidas
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
ES485567A0 (es) Procedimiento para la preparacion de azolilcetales
MX5955E (es) Procedimiento para la preparacion de derivados de piridoxina
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
ES488835A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
AR223434A1 (es) Procedimiento para la preparacion de derivados de i-piperidino-ftalazina
MX5445E (es) Procedimiento para la preparacion de derivados de isotiocianobenzotiazol
MX6158E (es) Procedimiento para la preparacion de derivados piperazinilbenzoheterociclicos